Akèy › Leksemi limfoblastik egi › Oklahoma
Etid klinik pou Leksemi limfoblastik egi nan Oklahoma
8 etid pou Leksemi limfoblastik egi ap chèche patisipan nan sit nan Oklahoma.
Vil nan Oklahoma
Tèks ofisyèl etid la (Anglè)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Oklahoma City, Oklahoma City
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05334069The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- University of Oklahoma Health Sciences Center, Oklahoma City
Ap rekriteFaz 1/2
Jiska laj 22 · Tout sèks · Mizajou Aug 25, 2026 · NCT04726241Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Board of Regents of the University of Oklahoma Health Sciences Center, Oklahoma City
Ap rekriteEtid obsèvasyon
1 Day – 17 Years · Tout sèks · Mizajou Aug 14, 2026 · NCT06274788Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
- Saint Francis Children's Hospital, Tulsa
Ap rekriteFaz 2
Laj 1 a 18 · Tout sèks · Mizajou Jul 16, 2026 · NCT06533748Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- Saint Francis Children's Hospital, Tulsa
Ap rekriteFaz 4
Laj 1 a 18 · Tout sèks · Mizajou Jul 14, 2026 · NCT06289673A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Oklahoma Health Science Center, Oklahoma City
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- University of Oklahoma Health Sciences Center, Oklahoma City
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152Pilot Imaging Study of Leukemia
- University of Oklahoma Health Sciences Center, Oklahoma City
Ap rekriteFaz 1
Laj 4 a 80 · Tout sèks · Mizajou Apr 23, 2026 · NCT03633955Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.